A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/10/2011	WO2011137601A1 Compound pharmaceutical formulation of levoamlodipine
11/10/2011	WO2011137587A1 Cytokine inhibitors
11/10/2011	WO2011137540A1 Gfi1b modulation and uses thereof
11/10/2011	WO2011137528A1 Methods and compounds for inhibiting glycosyltransferases
11/10/2011	WO2011137516A1 Flavonoid dimers and their use
11/10/2011	WO2011137511A1 Compounds, compositions and methods for treatment of central nervous system injuries
11/10/2011	WO2011137503A1 Methods for preparing ruthenium phosphine complexes with a structure containing picolinate and/or diimine and/or biphosphine ions, ruthenium phosphine complexes obtained by these methods and uses thereof
11/10/2011	WO2011137491A1 Novel drug delivery system
11/10/2011	WO2011112893A9 Compositions for ameliorating cell proliferative disorders and methods of making and using them
11/10/2011	WO2011110854A3 The use of amisulpride as an anti-emetic
11/10/2011	WO2011110166A3 Solid pharmaceutical composition, comprising donepezil hydrochloride of the crystalline polymorphous form i
11/10/2011	WO2011107812A3 Stabilized pharmaceutical composition
11/10/2011	WO2011104652A3 Veterinary compositions
11/10/2011	WO2011103150A3 Lyophilized preparations of bendamustine
11/10/2011	WO2011096642A3 Pharmaceutical composition for preventing and treating inflammatory diseases
11/10/2011	WO2011093612A3 Oral complex composition comprising pseudoephedrine and levocetirizine
11/10/2011	WO2011090741A3 TREATMENT OF TUMOR PROTEIN 63 (p63) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO p63
11/10/2011	WO2011090740A3 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
11/10/2011	WO2011090265A3 Composition containing cinchonine as an active ingredient for preventing and treating obesity, dyslipidemia, fatty liver, or insulin resistance syndrome
11/10/2011	WO2011088413A3 Lyophilized cake formulations
11/10/2011	WO2011088126A3 Treatment of viral infection with prenyltransferase inhibitors
11/10/2011	WO2011088075A3 Novel salts, polymorphs, and synthetic processes regarding imidazole derivative
11/10/2011	WO2011087795A3 Methods of using small compounds to enhance myeloid derived suppressor cell function for treating autoimmune diseases
11/10/2011	WO2011086574A3 Formulations of nano-carriers and methods of preparing the same
11/10/2011	WO2011085009A3 Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetate, and uses thereof
11/10/2011	WO2011084781A3 Oral care compositions and methods
11/10/2011	WO2011084571A3 Azide derivatives for phototherapy
11/10/2011	WO2011084514A9 Methods and compositions for treating a malaria-related complication
11/10/2011	WO2011084433A3 Aza-bridged ring-fused indoles and indolines
11/10/2011	WO2011082384A3 Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
11/10/2011	WO2011082283A9 Management of myoclonus with oral liposomal reduced glutathione
11/10/2011	WO2011082269A3 Substituted benzo-pyrimido-tetrazolo-diazepine compounds
11/10/2011	WO2011082245A3 Metalloenzyme inhibitor compounds
11/10/2011	WO2011081970A3 MOLECULES RELATED hERG Ion CHANNELS AND THE USE THEREOF
11/10/2011	WO2011081493A3 Pharmaceutical composition comprising metformin and rosuvastatin
11/10/2011	WO2011081445A3 Treatment use of ethylamino benzoic acid derivatives
11/10/2011	WO2011081430A3 Polymer nanoparticle injection formulation composition containing rapamycin with improved water solubility, preparation method thereof, and anticancer composition for combined use with radiotherapy
11/10/2011	WO2011081408A3 Imatinib dichloroacetate and anti-cancer agent comprising the same
11/10/2011	WO2011081373A3 Method for preparing highly pure anhydrous crystalline docetaxel
11/10/2011	WO2011080502A3 New pharmaceutical dosage form for the treatment of gastric acid-related disorders
11/10/2011	WO2011080500A3 New pharmaceutical dosage form for the treatment of gastric acid-related disorders
11/10/2011	WO2011079273A3 Methods and compositions for cardiovascular diseases and conditions
11/10/2011	WO2011076873A9 Influenza targets
11/10/2011	WO2011076784A3 New inhibitors of cyclophilins and uses thereof
11/10/2011	WO2011074903A3 Pharmaceutical composition containing a3 adenosine receptor agonist
11/10/2011	WO2011072287A3 Method for late introduction of the (8r)-hydroxyl group in carbapenem beta-lactam antibiotic synthesis
11/10/2011	WO2011070529A3 Dextrin hydrogel for biomedical applications
11/10/2011	WO2011068987A3 Compositions and methods for the treatment of giardiasis
11/10/2011	WO2011068386A3 Anticancer composition containing a kampheride compound as an active ingredient
11/10/2011	WO2011066201A3 Methods and systems for treating and preventing cardiac injury in dystrophic subjects
11/10/2011	WO2011059265A3 Process for preparing extract fraction enriched with ginsenoside rg3 from ginseng radix
11/10/2011	WO2011053801A4 Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye
11/10/2011	WO2010143169A3 Compounds useful for treating aids
11/10/2011	WO2010134025A3 Oral compositions of celecoxib
11/10/2011	WO2010119369A3 A medicinal cream made using silver sulphadiazine and chitosan and a process to make it
11/10/2011	WO2010109330A3 Cholesterol level lowering liposomes
11/10/2011	WO2010093706A3 Chemically programmed vaccination
11/10/2011	WO2010092450A8 Stable pharmaceutical composition for atherosclerosis
11/10/2011	WO2010078294A8 Method of preparing (+)-1,4-dihydro-7-[(3s,4s)-3methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
11/10/2011	WO2008062206A8 Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis c virus
11/10/2011	US20110275827 Mitotic Kinesin Inhibitor
11/10/2011	US20110275810 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
11/10/2011	US20110275722 Propofol based anesthetic with preservative
11/10/2011	US20110275721 Method for the purification of substituted cyclopent-2-en-1-one congeners and substituted 1,3-cyclopentadione congeners from a complex mixture using countercurrent separation
11/10/2011	US20110275720 Methods for concomitant administration of colchicine and a second active agent
11/10/2011	US20110275719 Novel trifluoromethylsulfonamide gamma secretase inhibitor
11/10/2011	US20110275718 Pharmaceutical composition of ibuprofen and paracetamol and methods of using the same
11/10/2011	US20110275717 Pharmaceutical formulation comprising diclofenac
11/10/2011	US20110275716 Composition and method for treatment of diabetes
11/10/2011	US20110275715 Method for treating retinal disease
11/10/2011	US20110275713 Acetylated amino acids as Anti-platelet agents, Nutritional And Vitamin Supplements
11/10/2011	US20110275711 Method for treating macular edema
11/10/2011	US20110275709 Tellurium-containing compounds for affecting male's fertility following chemotherapy and/or radiotherapy
11/10/2011	US20110275708 Polycyclic compounds and methods related thereto
11/10/2011	US20110275707 Substituted afpo (6-aryl-4h-furo[3,2-c]pyran-4-one) derivatives as anti-cancer agents
11/10/2011	US20110275706 Pharmaceutical Compositions Containing Lipase Inhibitors
11/10/2011	US20110275705 Stable injectable oil-in-water docetaxel nanoemulsion
11/10/2011	US20110275704 Stable Formulations for Lyophilizing Therapeutic Particles
11/10/2011	US20110275703 Substituted spiroketal derivatives and use thereof as therapeutic drug for diabetes
11/10/2011	US20110275702 Novel DNA Nanostructures that Promote Cell-Cell Interaction and Use Thereof
11/10/2011	US20110275701 Anti-thrombin aptamer formulations and methods for use
11/10/2011	US20110275700 Biodegradable polyketal polymers and methods for their formation and use
11/10/2011	US20110275699 Treatment For Obesity And Diabetes
11/10/2011	US20110275698 "test and treat" strategy for treating transforming hpv infection
11/10/2011	US20110275697 Regulation of cyclin d
11/10/2011	US20110275696 Thioxanthone-Based Autophagy Inhibitor Therapies to Treat Cancer
11/10/2011	US20110275695 Crystalline forms of zotepine hydrochloride
11/10/2011	US20110275694 3-(phenoxyphenylmethyl)pyrrolidine compounds
11/10/2011	US20110275693 Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine Derivatives
11/10/2011	US20110275692 Substituted gamma lactams as therapeutic agents
11/10/2011	US20110275691 Methods of treating headaches using 5-ht agonists in combination with long-acting nsaids
11/10/2011	US20110275690 New crystal form of sunitinib malate
11/10/2011	US20110275689 Preparation of 3-Pyrrole Substituted 2-Indolinone Derivatives
11/10/2011	US20110275688 Ketorolac compositions for corneal wound healing
11/10/2011	US20110275687 Saxagliptin intermediates, saxagliptin polymorphs, and processes for preparation thereof
11/10/2011	US20110275686 Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt)
11/10/2011	US20110275685 Salt and polymorphs of a kinesin inhibitor compound
11/10/2011	US20110275684 Novel benzotriazole derivatives useful for the treatment of cns disorders
11/10/2011	US20110275683 Selenophene and Selenazole Carboxylic Acid Derivatives
11/10/2011	US20110275682 Novel choline cocrystal of epalrestat

1 ... 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 ... 7860